Quickstart Highlights
CJC1295 NO DAC + Ipamorelin 10mg dosage protocol supports enhanced growth hormone release and recovery through daily subcutaneous injections.
- Typical total daily dose ranges from 300–600 mcg for most protocols
- 5-days-on, 2-days-off schedule is common to prevent receptor desensitization
- Gradual titration approach to optimize tolerability and results
- Reconstitute to a practical concentration for accurate syringe measurements
- Store lyophilized in the freezer; keep reconstituted vials refrigerated
Important: Before viewing any protocol, please consult our Prep & Injection Guide for essential preparation and safety instructions.Dosing & Reconstitution Guide
Educational guide for reconstitution and daily dosing
Standard / Gradual Approach (3 mL = ~3,333 mcg/mL)
| Week | Daily Dosage (mcg) | Units (approx.) |
|---|---|---|
| Weeks 1–4 | 300 mcg (once daily) | ~9 units |
| Weeks 5–8 | 500 mcg (once daily) | ~15 units |
| Weeks 9–12 | 600 mcg (once daily) | ~18 units |
| Weeks 13–16 (Optional) | 700 mcg (once daily) | ~21 units |
Reconstitute with 3 mL of bacteriostatic water to achieve an approximate 3,333 mcg/mL concentration. Note that 300 mcg requires about 9 units, which is slightly below 10. If higher precision is needed, consider using a 50-unit or 30-unit syringe.
- Draw 3.0 mL of bacteriostatic water into a sterile syringe.
- Inject the water slowly along the vial wall to minimize foam.
- Gently swirl—avoid vigorous shaking.
- Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.
Advanced / Aggressive Approach (2 mL = 5,000 mcg/mL)
| Week | Daily Dosage (mcg) | Units (approx.) |
|---|---|---|
| Weeks 1–4 | 600 mcg (once daily) | ~12 units |
| Weeks 5–8 | 800 mcg (once daily) | ~16 units |
| Weeks 9–12 | 1,000 mcg (once daily) | ~20 units |
| Weeks 13–16 (Optional) | 1,200 mcg (once daily) | ~24 units |
For those requiring higher daily doses (600–1,200 mcg), reconstitute with 2 mL to achieve 5,000 mcg/mL. This helps keep injection units comfortably above 10.
- Draw 2.0 mL of bacteriostatic water into a sterile syringe.
- Inject slowly to prevent excess foaming or bubbling.
- Gently roll/swirl the vial—avoid vigorous shaking.
- Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.
Note: This guide is for educational purposes only. Always consult with a qualified healthcare professional.
Supplies Needed
Ensure you have these on hand for an 8–16 week cycle.
- Peptide Vials:
• 8 wks ≈ 2 vials
• 12 wks ≈ 3 vials
• 16 wks ≈ 4 vials
(More if planning higher doses or extended use) - Insulin Syringes:
• 8 wks ≈ 40 syringes (daily use, 5 days on/2 days off)
• 12 wks ≈ 60 syringes
• 16 wks ≈ 80 syringes - Bacteriostatic Water: 1× 30 ml (or more as needed)
- Alcohol Swabs: 1 box
![Peptide Vial](http://www.dosagepeptide.com/wp-content/uploads/2025/12/Primelab_Powder_GROW-H-1-scaled.png" alt="CJC-1295 no DAC & Ipamorelin (10mg Blend Vial)" /></div>)
Protocol Overview
A concise summary of this daily subcutaneous injection regimen.
- Goal: Enhance growth hormone release and support recovery
- Schedule: Typically 5 days on, 2 days off (e.g., Monday–Friday)
- Dose Range: 300–600 mcg daily for most researchers, with advanced users reaching 1,000+ mcg
- Reconstitution: Aim for 2–3 mL for easy measuring on insulin syringes
- Storage: Lyophilized vials in the freezer; reconstituted vials in the refrigerator
Dosing Protocol
Suggested once-daily injection approach for consistent GH pulses.
- Daily Dose: Start at ~300 mcg; gradually increase as tolerated
- Frequency: Daily injections, 5 on/2 off per week
- Cycle Length: 8–16 weeks, followed by a rest period to maintain receptor sensitivity
- Advanced Doses: May exceed 600 mcg daily based on research goals
- Timing: Best on an empty stomach; morning or before bed
Storage Instructions
Proper storage ensures peptide integrity.
- Lyophilized: Store in a freezer (−20°C) for maximum shelf life
- Reconstituted: Keep at 2–8°C (refrigerated)
- Use within 30 days of mixing; avoid exposing reconstituted solutions to heat/light
- Avoid frequent freeze-thaw cycles
Important Notes
Practical tips to enhance safety and efficacy.
- Rotate injection sites and always use new, sterile syringes.
- For best results, inject on an empty stomach and wait ~30 minutes before eating.
- Monitor for adverse reactions; discontinue use if serious issues arise.
- Track progress weekly; adjust dosage and protocol duration as research suggests.
How This Works
CJC1295 NO DAC combined with Ipamorelin synergistically boosts growth hormone release.
- CJC1295 NO DAC: Stimulates pituitary gland to release endogenous GH
- Ipamorelin: A selective ghrelin receptor agonist that amplifies GH pulse
- The blend mimics natural pulsatile GH secretion with fewer side effects
Potential Benefits & Side Effects
Research suggests improvements in recovery, body composition, and sleep quality.
- Enhanced muscle recovery and repair
- Improved sleep patterns and overall restfulness
- Possible side effects include mild water retention, headaches, or joint discomfort
- Less common: injection-site irritation or transient flushing
Injection Technique
- Clean the vial stopper and skin with alcohol; allow to dry.
- Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[7].
- Do not aspirate for subcutaneous injections; inject slowly and steadily[8].
- Rotate sites systematically (abdomen, thighs, upper arms) to avoid local tissue changes[11].
- Withdraw the needle at the same angle; dispose immediately in a sharps container.
Lifestyle Factors
Complement your protocol with healthy habits for optimal outcomes.
- Adopt a balanced, protein-rich diet to support muscle and tissue repair
- Incorporate regular exercise, focusing on both strength and cardiovascular health
- Prioritize stress management and quality sleep
Recommended Source
We recommend Prime Lab Peptides for high-purity CJC-1295 + GHRP-2 (10 mg Blend).
Why Prime Lab Peptides?
- High-purity, third-party-tested lots with batch COAs.
- Consistent, ISO-aligned handling and documentation.
- Reliable fulfillment to maintain cold-chain integrity.
Important Note
This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.
References
References
-
PubMed
— Prolonged stimulation of GH and IGF-1 secretion by CJC-1295 in healthy adults -
PubMed
— Once-daily CJC-1295 normalizes growth in GHRH knockout mouse -
PubMed
— Ipamorelin, the first selective growth hormone secretagogue -
PMC
— Beyond the androgen receptor: GH secretagogues in body composition management -
PubMed
— Pharmacokinetic-pharmacodynamic modeling of ipamorelin in human volunteers -
PubMed
— Ipamorelin GH pulse kinetics and timing studies -
CDC
— Vaccine administration: subcutaneous route (angle/site; no aspiration) -
CDC (Subcut Injection PDF)
— Technique diagram and site guidance for subcutaneous injections -
NCBI Bookshelf
— Best practices for injection (asepsis, preparation, and administration) -
Subcutaneous Drug Injection Review (PMC)
— Pharmacologic considerations of the subcutaneous route -
Frontiers in Endocrinology
— Growth hormone secretagogues: history and clinical applications -
Endocrine Reviews
— Ghrelin and growth hormone secretagogues: physiology and applications -
Prime Lab Peptides
— CJC-1295 NO DAC + Ipamorelin (10 mg Blend) product page